Important NoticeThis app is for educational purposes only. You must be 18+ to use it. We do not sell any peptides on this site.

Peptide Library / Detail
Half-life
Approximately 30-60 minutes (varies by delivery method and formulation)
Delivery
Subcutaneous or intravenous injection in research settings; synthetic analogs and modified forms under development for improved stability
Dosage
—
Research Use Only
All products listed are for laboratory research only — not for human consumption. By browsing, you acknowledge these terms.
Humanin is a naturally occurring mitochondrial-derived peptide (MDP) consisting of 24 amino acids that plays a crucial role in cellular protection and metabolic regulation. It is encoded within the mitochondrial genome and acts as a cytoprotective factor against oxidative stress, inflammation, and cellular aging. Humanin has emerged as a promising therapeutic target for metabolic disorders, neurodegenerative diseases, and age-related conditions.
Humanin is primarily studied in research settings with dosing protocols varying based on the condition and delivery method. Typical research protocols involve subcutaneous or intravenous administration with dosages ranging from micrograms to milligrams per kilogram body weight. In animal studies, daily or intermittent dosing regimens have been employed. Clinical research in humans is still in early stages, with optimal dosing and frequency yet to be established.
Humanin exerts its cytoprotective effects by binding to multiple cellular receptors, including the CNTFR/WSX-1/gp130 trimeric receptor complex and FPRL1/2. It activates survival signaling pathways such as PI3K/AKT and STAT3, while inhibiting pro-apoptotic proteins like BAX and Bid. Humanin reduces oxidative stress by enhancing mitochondrial function, decreasing reactive oxygen species production, and suppressing inflammatory cascades including NF-κB activation. It also modulates cellular metabolism and insulin sensitivity.